text:
Find out if you could save money on bills you have already paid. Don't worry… It won't cost you a penny to find out!
We've got your back.
Your utility providers aren't looking out for you, but we will. On average, 80% of companies are overcharged on utility expenses, and you have a right to get that money back! We'll audit years' worth of bills for you, finding overcharges, eliminating mistakes and obtaining refunds for you when possible. If we don't find you any refunds or reduction opportunities, you don't pay us a thing. Whatever we find, we split 50/50. We can audit the following utility bills for you — at no upfront cost, risk or obligation.
What's included.
An audit will make sure you are receiving accurate billing from your providers. Not only is it possible to get money BACK that you've already paid, but we can also correct errors on future bills to ensure future reductions. Working with Viv is the easiest way to decrease monthly expenses and give yourself a competitive advantage.
- Audit includes all local, long distance, wireless, data and internet charges
- Evaluate cost-effectiveness of line charges, usage charges and feature packages
- Constant monitoring of changes in the industry to consolidate where possible and remove redundancies and outdated charges
- Refunds for errors and overcharges back to the point of the error
- Audit includes all electric, water/sewer and natural gas bills
- Full analysis of current and past usage to ensure tariffs and meter reads are correct
- Removal and correction of meter errors, demand errors, rate structures and unnecessary minimum charges and analysis of utility budgetary spending
- Refunds for errors and overcharges dating back 3-4 years
Don't let your refunds expire!
Many states have a 36-month statute of limitations on reporting and refunding erroneous charges. Let us find you that money before it's too late!
Here's how it works.
We can get started with just a few months of bills, plus any original contracts.
We'll assign specialized auditors for your location and bill types to look for errors, discrepancies or overcharges.
You'll receive a detailed update on any of our findings within 6-8 weeks. This will include your options for implementing any refunds or reductions.
With your permission, we'll obtain refunds or reductions with your utility and ensure your errors and omissions are corrected on future savings.
You'll receive your refunds and/or begin to benefit from ongoing reductions from corrections. We'll assure future bills remain error-free.
If you don't save, you don't pay.
At Viv our mission is simple: We want to make your life better by saving you money, automatically and hassle-free. There is no better or easier way to lower your overhead costs than to let us review, audit and manage your bills. When you save, we make money. If we can't save you money, we don't charge you. It's that simple. With nothing to lose, get started today!
Is my business eligible?
If you are a commercial business or corporation that has more than a year of utility bills, you probably are! We do audits in all 50 states for companies of all sizes ranging from small family-owned restaurants to large manufacturing plants, franchises, non-profits, hospitals, and stadiums. We also work regularly with municipalities, educational facilities and more. Whether you have one location or several with multiple utility providers, we can help!
How do I know if I have overcharges or errors?
The odds are that you do! More than 80% of our invoice audits have overcharges and errors. The only way to know if you are being overcharged or if your bills contain errors is to perform an audit to get that money back and have future bills corrected.
What bill type should I start with?
We strongly recommend you have us work on all your bills. There's no risk to you and if your gas utility provider is not overcharging you, your electric or sewer utility very well maybe! Remember that any un-audited findings continue to cost you money month after month and there is often a time limit to when you can reclaim these funds. Let us work on all your bills so you don't go a single month longer than necessary before you can have the peace of mind knowing you are being billed fairly and accurately.
What kinds of errors might you find?
Some of the most common errors we find are in tariff and tax classifications, meter readings, charges for non-existing services and complex billing codes. We know what to look for and where to find it!


text:
Update: Monday, July 16
Above is a chart that was part of a zerohedge article on the Amazon insurrection in Europe. As I've written before, you'll find EW trends throughout society and here's another example. If I was Jeff and understood how trends unfold, I'd be worried. After 5 waves up, the trend will reverse. We're not quite there yet, but it won't be long …
They're Rare. But They're Everywhere!
It didn't take long for the SP500 to completely upset last week's apple cart. I finished the report on last weekend and by the end of the day Monday, the SP500 had determined that it was going to head higher and trace out an ending diagonal. I'd given up on that idea a couple of weeks earlier.
Way back in May, an ending diagonal had been my first expectation for the unfolding triangle pattern in both the SP500 and ES (emini futures). That was partly because of all the other ending diagonals in other indices.
But the third wave of the triangle headed south unexpectedly in mid June at the 2796 level. What was unusual is that the turn down was in three waves (rather than the usual five waves). Five wave moves signal more to come in the same direction; three wave moves retrace.
Above is the 2 hour chart of the SP500, which is now brandishing an ending diagonal, as are so many other assets. You can see that the upper trendline now has a rising slope. Each of waves one, three, and five must seek a new high in an ED.
I remarked at the time that it was an odd way to start the E leg of a contracting triangle, because waves within triangles are typically recognizable corrective patterns (ie – flats, zigzags, triangles, and even ending diagonals). They are not three wave patterns. But I've had to temper some of my expectations in a market that's proven to be volatile and somewhat unpredictable (within the confines of the current triangle pattern).
Well, the turn down in three waves was the market giving a very subtle message that it wasn't done with the upside, as it showed us this week.
The Nasdaq, NDX, NQ, Russell 2000 and 3000 have all now traced out ending diagonals.
This past Monday, when ES rose above 2760, it became very obvious to me that an ending diagonal for the SP500 and ES (futures) was back on the table, even though these indices were displaying underlying weakness.
I consider an ending diagonal a corrective pattern. They appear at the ends of waves—third waves, fifth waves, and C waves. They warn of a pending change in trend. They also "cap" the trend, in that they set a limit as to how far the final fifth wave of the pattern can travel (the final fifth wave cannot be longer than the third wave of the diagonal).
On Friday, the SP500 technically confirmed an ending diagonal when the third wave of the pattern (previously the D wave of the contracting triangle) made it to a new high above 2802.
I don't yet have a target for the final wave up, and may not have one for a couple of weeks. That's because the fourth wave of an ending diagonal must be fully in place before you can project a maximum length (and target) for the final fifth wave.
But, at this point we know that the trend is at an end (or almost so). We actually knew that because of all the other ending diagonals in the other major indices. So does a contracting triangle, but an ED is a much more dramatic statement that the trend is extremely limited.
Even though ending diagonals are considered relatively rare, they just happen to be all over the place in this market. Following are some charts that show ending diagonals taking shape in a number of major assets.
Above is the 2 hour chart of NDX (Nasdaq 100). The upper parallel line is the limit for the blue wave 3 based upon the measured length of blue wave 1. Wave 3 cannot be longer than wave 1. We're at the top.
Above is the 4 hour chart of IWM (Russell 2000). Note the shape of the third wave. You'll find this distinctive ABC pattern in almost all ending diagonals.
Above is the 2 hour chart of IWV (Russell 3000). This index is not as bullish as the others. Wave 5 will have to get to an all time new high, though, above 169.21.
Above is the 7 day chart of TSX (Toronto Composite Index). I often refer to this as the scariest chart I've ever seen, due to the fact that this ending diagonal is ten years long!
Above is the 3 day chart of INTC (Intel Corp). Wave 4 must drop enough to reside horizontally within the area of wave 1 (it must drop to at least $37.90, which is the top of wave 1).
Above is the 4 hour chart of BABA (Alibaba Group). A rather bearish version of an ending diagonal.
Above is the 8 day chart of GS (Goldman Sachs).
Above is the 4 hour chart of AAPL (Apple).
They're everywhere! The long awaited change in trend is indisputable, and almost at hand!
Elliott Wave Basics
There are two types of Elliott wave patterns:
- Motive (or impulsive waves) which are "trend" waves.
- Corrective waves, which are "counter trend" waves.
Motive waves contain five distinct waves that move the market forward in a trend. Counter trend waves are in 3 waves and simply correct the trend.
All these patterns move at what we call multiple degrees of trend (in other words, the market is fractal, meaning there are smaller series of waves that move in the same patterns within the larger patterns). The keys to analyzing Elliott waves is being able to recognize the patterns and the "degree" of trend (or countertrend) that you're working within.
Impulsive (motive) waves move in very distinct and reliable patterns of five waves. Subwaves of motive waves measure out to specific lengths (fibonacci ratios) very accurately. Motive waves are the easiest waves to trade. You find them in a trending market.
Waves 1, 3, and 5 of a motive wave pattern each contain 5 impulsive subwaves. Waves 2 and 4 are countertrend waves and move in 3 waves.
Countertrend waves move in 3 waves and always retrace to their start eventually. Counrtertrend (corrective waves) are typically in patterns — for example, a triangle, flat, or zigzag. Waves within those patterns can be difficult to predict, but the patterns themselves are very predictable.
Fibonacci ratios run all through the market. They determine the lengths of waves and provide entry and exit points. These measurements are really accurate in trending markets, but more difficult to identify in corrective markets (we've been in a corrective market in all the asset classes I cover since 2009).
To use Elliott wave analysis accurately, you must be able to recognize the difference between a trend wave (motive) and a countertrend wave (corrective). There's very much more to proper Elliott wave analysis, but this gives you the basics.
Registration for Commenting
Want to comment? You need to be logged in to comment. You can register here.
If you register, it protects your information. It also allows you to comment without filling in your information each time. Once you're registered, simply go to the home page and click on the login link top right in order to log yourself in. Usually, you'll be logged in for several days before needing to be logged in again.
Problem receiving blog comment emails? Try whitelisting the address. More info.
The Market This Week
Here's the latest daily chart of ES (emini futures)
Above is the daily chart of ES (click to enlarge, as with any of my charts).
I commented this past week in a nightly video for my Trader's Gold subscribers that this market is going to one that I'll remember for a long time. That's primarily because the NYSE is tracing out a contracting triangle (a corrective pattern that's almost evenly balanced between bulls and bears, and moves sideways). Because it's summer, this balance is exacerbated by extremely low volume, which leads to volatility. As well as low volume due to summer, we're at the top of a 500 year rally (everybody who wants to be in the market, is).
Sentiment is at historically bullish levels, but the smart money has been leaving for quite some time.
The market is volatile and at times unpredictable. It moves to extremes in both directions (due to its "balanced" nature). On top of that, all major asset classes are moving in tandem at the whim of the US Dollar. As a result, assets tend to get "pushed around" when they react to some of the volatile moves the buck has exhibited over the past few months.
It's a great time to be on holidays and not in the market!
Monday of this past week, I predicted that wave D of the SP500 was indeed going to a new high (resulting in an ending diagonal). On Friday, we achieved that goal. But it became clear midday on Friday that we'd have to wait until Monday for the turn to the downside.
The wave down will be the fourth wave of the ending diagonal, with a target somewhere near 2600-25.Then we'll turn up into the fifth and final high ... but a high that will have a definite maximum target (to be determined once the fourth wave is fully in place.
Summary: We should turn down early this week into the fourth wave of an ending diagonal. Once the 4th wave (down) is complete, expect a final fifth wave to a new high. That fifth wave up to a new high will be the end of the 500 year bull market.
Trader's Gold Subscribers get a comprehensive view of the market, including hourly (and even smaller timeframes, when appropriate) on a daily basis. They also receive updates through the comments area. I provide only the daily timeframe for the free blog, as a "snapshot" of where the market currently trades and the next move on a weekly basis.
Sign up for: The Chart Show
Next Date: Wednesday, July 25 at 5:00 pm EST (US market time)
The Chart Show is a one hour webinar in which Peter Temple provides the Elliott Wave analysis in real time for the US market, gold, silver, oil, major USD currency pairs, and more. You won't find a more accurate or comprehensive market prediction anywhere for this price.
Get caught up on the market from an Elliott Wave perspective. You'll also get Andy Pancholi cycle turn dates for the SP500 for the balance of the current month. There'll be a Q&A session during and at the end of the webinar and the possibility (depending on time) of taking requests.
All registrants will receive the video playback of the webinar, so even if you miss it, you'll be sent the full video replay within about an hour of its conclusion. For more information and to sign up, click here.

subset: commoncrawl


text:
True Confessions
- 7,99 €
- 7,99 €
Beschreibung des Verlags
Welcome to Gospel, Idaho, where everyone knows that there are two universal truths. First, God did His best work when He created the Sawtooth Wilderness Area. Second, every sin known to heaven and earth—from the hole in the ozone to alien abductions—is all California's fault.
This is the story of what happened when a Californian came to visit . . .
Hope Spencer knows wacky: as a writer for The Weekly News of the Universe she's "spotted" Bigfoot, Elvis, and the face of Jesus on a tortilla. Arriving in Gospel hoping for some peace and quiet and normal . . . she quickly figures out that there's nothing normal going on in Gospel. From the Barnes sisters with their color-coordinated hair, to the toilet-tossing sportsmen . . . to the murder victim whose body had been found in her house years before, the Gospel truth really is stranger than fiction—even tabloid fiction. Hell, she should have stayed in L.A.
And then there's local sheriff Dylan Taber. He's no made-up character from one of her stories. She could never create anything that good. Dylan's all too real . . . and soon Hope is forced to face the awful truth—she's been too long without a man. But once she gets wind of a Hollywood actress somehow mixed up in Dylan's life, Hope realizes that if they are to have any chance together, he has some true confessing to do.


text:
Press Release
Sydney, 15 May 2009
Geoff Winestock's 13 May 2009 article titled "Sometimes less can be rather Moore" has made a number of factually inaccurate and misleading assertions and statements.
First, the article implies that the composition of the Directors' Profit Share (DPS) portfolio is being manipulated. It states: "the portfolio was adjusted over the past two years of the global financial crisis so that they received much better returns"; it implies that poorly performing stocks are dropped to enhance performance; and it suggests that a "DPS financial planner" is used to assist with stock selection. In contrast to these assertions, the Macquarie Group Remuneration Report, at page 81, discloses that the Board Remuneration Committee annually makes a determination about the composition of each Executive Director's portfolio to ensure it is aligned with their management responsibilities. When Mr Moore became Managing Director and CEO in 2008, his portfolio was adjusted to reflect his expanded responsibilities. In addition, 35 per cent of his 2009 DPS was invested in Macquarie shares.
Second, the article suggests that the portfolio is not being appropriately valued. It suggests that "artificial values" are being used for listed stocks, instead of market prices and that the indicative value of the portfolio can be calculated based on the stock prices of three listed funds, namely Macquarie Airports, Macquarie Countrywide and Macquarie Infrastructure. The assertions are simply wrong. Listed stocks in the portfolio are valued based on total shareholder returns (listed prices, adjusted for dividends) and the portfolio consists of a very broad cross-section of Macquarie funds, including foreign funds, which are also impacted by foreign exchange rate movements.
Third, the article makes repeated comparisons between the portfolios in which the executives are invested and Macquarie Group shares. There is no linkage because the DPS is not invested in Macquarie shares.
Finally, it is implied that the way the portfolio is valued will provide a benefit to executives in the transition to Macquarie's proposed remuneration scheme to be put to shareholders at Macquarie's AGM. This is misleading and incorrect. As pointed out above, the valuation methodology is robust and there is no additional benefit to executives. Moreover, in the case of Mr Moore, since 2008, a portion of his profit share (10 per cent in 2008 and 35 per cent in 2009) is already invested in Macquarie shares, with 20 per cent in the DPS.
Yours sincerely
Greg Ward
Chief Financial Officer
Australia and New Zealand
Email regional contact
Email regional contact
Email regional contact
Europe, Middle East and Africa
Email regional contact


text:
Raven Man T-shirt
Safe & Secure Checkout
Experience ultimate comfort with our premium 100% Airlume combed and ring-spun cotton t-shirt.
Looking for a tee that's as comfortable as it is stylish? Look no further than our premium 100% Airlume combed and ring-spun cotton t-shirt. This tee is made from the softest, most breathable cotton you'll ever feel, and it's built to last.
Join the conscious fashion movement. Every tee is made just for you, reducing waste and protecting the environment. Together, we can create a more sustainable future.
Here's why it takes a bit longer:
- Made to order: We don't create excess inventory, which contributes to overproduction and waste.
- Thoughtful production: Each tee is crafted with care, reducing the environmental impact.
Thank you for choosing sustainable fashion!
Our commitment to sustainability and ethical practices extends to our entire supply chain. We work exclusively with certified suppliers who meet the highest standards for sustainability, ethical working conditions, and environmental responsibility.
Because your items are uniquely crafted just for you, please note that production takes 3-5 business days. Then, your order will be shipped out!
Hassle-free Return
We want you to love your purchase! If you're not completely satisfied, we offer a 30-day return policy from the date you receive your item. Please ensure the item is unworn, unused, with tags, and in its original packaging. Don't forget to include your receipt or proof of purchase.


text:
All content on this site is protected by copyright. The educational resources on this site may be used, reproduced and distributed by instructors for non-commercial, educational purposes without additional permission. Any other reproduction or use of content from this site requires the user to obtain copyright clearance.
Title: Floating Mushroom
Artist: Dennis Vance
Pictured: Gerry Gilbert
Artist: Michael de Courcy
Date: September 30, 1969
Format: Photograph [fibre based gelatin silver print]
Location: The Michael de Courcy Archive
Size: 12.70 × 10.20 cm
More Information: An electronic sound work by Dennis Vance entitled "Floating Mushroom". "Floating Mushroom" was a floating steel form containing sound generating equipment that responded to movement on the shore. This intervention took place at Lost Lagoon in Vancouver. L-R: Ian Ridgeway, Dalla Selman (with Portapack video camera) Gerry Gilbert, Heidi Ridgeway, Galen Ridgeway, Kita Ridgeway. Collection of the artist.
Discrete project sites documenting the work of specific artists and collectives in detail.
Essays and conversation providing a context for exploring the Project Sites and Archives.
Video interviews conducted between December 2008 and May 2009 reflecting on Vancouver's art scene in the sixties.


text:
Monday, February 18, 2013
Kayak: Trinity River Elm Fork
iPhotos © Mark M. Hancock / DFWmark.com
Morning light is a good companion during a paddle on the Trinity River between Sam Houston Trail Park and McInnish Park in Irving on Sunday, July 29, 2012.
See a larger version of this slideshow.
The Elm Fork of the Trinity River runs from Lake Lewisville to Downtown Dallas, where it merges with the main Trinity River. It is home to an array of wildlife and a ribbon of calm solitude for kayak paddles through the heart of the Metroplex.
*All images made with an iPhone.
Dallas County,
photo story/essay,
Subscribe to:
Posts (Atom)


text:
Highest-rated sets
LEGO® | Disney sets
Find inspiration, share your creation
Read All About It
Welcome to the Official LEGO® Shop, the amazing home of LEGO building toys, gifts, stunning display sets and more for kids and adults alike. Find the perfect gift for toddlers, kids, teens and adults for birthdays or other occasions such as Valentine's Day, Mother's Day and Father's Day. We make it easy to shop for toys that will provide hours of fun and imaginative play. You'll also find curated LEGO sets for adults perfectly matching their interests, such as cars, flowers, gaming and much more!


text:
DE PERE ' Wisc. — It's taken 11-year-old Dane Steward plenty of determination and perseverance, but he hopes to soon hold a national record for consecutive jumps on a pogo stick.
"At first I could do like two, and then I wanted to try even more," Dane said. "And then, what made me want to do it is I wanted to know the feel of being a record holder and the feeling after."
Last month, he jumped for nearly three hours. To be exact, he jumped for two hours and 42 minutes with a total of 20,100 jumps.
Dane said when tried pogo stick jumping for the first time it was hard. But now, his skill is something he is really proud of.
"For me, it's hard because my arms aren't very long so to get over the fear, like that flip, is super hard. But once you have it down, it's pretty easy and fun," Dane said. "I did have a lot of determination, I knew I could do it so that pretty much kept me through it the whole time."
He said when he jumps he feels as if he's walking on the moon.
With aspirations for a career in astronomy, he says he only hopes his determination will carry him farther in his future endeavors.
"When he came up and asked if he could give it a try we looked into it and saw the other records that were held and he's like, 'I think I can beat it,' and in my mind I knew he could too," said Dane's mother, Stefanie.
Last month Dane set out to do the challenge, his mom recorded it all. They have submitted the video to RecordSetter.com who they are waiting to hear back from.
Corey Henderson, the CEO of Recorder Setter, said he created the site back in 2008 to inspire those like Dane to take their hobbies and interest to the next level.
"We had seen there was no place you could go and break you own world records and the idea of what world records were at the time were, like, the guy with the long finger nails and these kind of things," Henderson said. "We wanted world records that everybody could participate in and you can adventure in it."
This story was originally published by Valerie Juarez on Scripps station WGBA in Green Bay, Wisconsin.


text:
Paul Abbott works in politics. Follow Paul on Twitter
Last week, Dan Hodges asked a sensible question: "Where is the Liberal outrage over Mid Staffs?" He said:
"Mid Staffs is not a one-off. As this paper reports today, an additional 3,000 patients are believed to have died needlessly in five other trusts in Lancashire, Essex and Greater Manchester... And what has been the response to this institutionalised carnage? Or more specifically, the response from the radical left, the self appointed guardians of the National Health Service? Nothing but deflection or silence."
It's an important point. To be a credible party of One Nation, Labour must be willing to criticise the public sector where it fails. In the same way, Conservatives must be prepared to attack flaws in the private sector. If we don't, we are simply a pressure group for vested interests.
But nowhere is the silence on Mid Staffs more deafening, than the total, blank, enourmous, disappointing silence on the website 38Degrees.org
As ConservativeHome readers will know, 38Degrees made its name - and hoovered up more than one million online members - by campaigning to stop Andrew Lansley's NHS bill. "Save the NHS!" They cried, "Publish the risk register!" And so on. Anyone who worked in Parliament during that time will remember it. Millions of machine-emails were sent; postcards posted; surgeries attended; rallies and demonstrations held.
The Daily Mirror even put a tombstone on its front cover, with the words: "NHS, 1948-2012: KILLED BY THE COALITION". I remember walking to work at 8am, on a cold weekday, and a demonstrator (who for some reason did not have to be working) saw that I was going into Parliament, and shouted at me: "Scum destroying our NHS!" Given that two members of my close family have worked on the NHS frontline, this seemed a little aggressive. But tensions were running high.
Now that the Mid Staffs report has been published and debated in Parliament, it makes difficult and upsetting reading - wherever you fall on the political spectrum. Thousands died. The truth was covered up. Problems were endemic and not just because of a few rogue individuals. But, where is the 38Degrees campaign for NHS reform? Where is the e-petition on their website, saying, "24 hours to save the NHS"? In the past, they have moved quickly to jump on a topical news agenda. So why not now, on their central issue of defending the National Health Service?
38Degrees will have no credibility on NHS reform in the future, if they don't step up to the plate now. I've met the CEO of 38Degrees - David Babbs - a few times, and like him. He's a nice guy, and seems sincere in his intentions. He has told me more than once that he's not a front for the Labour Party, and I believe him.
But why the silence on Mid Staffs, David? What's going on?


text:
Burzynski: Cancer Is Serious Business from BurzynskiMovie on Vimeo.
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food and Drug Administration in American history.
In the 1970's, Dr. Burzynski made a remarkable discovery that threatened to change the face of cancer treatment forever. His non-toxic gene-targeted cancer medicine could have helped save millions of lives over the last two decades had his discovery not been criminally suppressed by the US government, as his therapy, called "antineoplastons," have been shown to effectively help cure some of the most "incurable" forms of terminal cancer.
This documentary takes you through the treacherous 14-year journey Dr. Burzynski and his patients have had to endure in order to finally obtain FDA-approved clinical trials of antineoplastons.
His story is yet another testament that fact can be far stranger than fiction, as the film exposes the powerful, unscrupulous forces that work to maintain the status quo of the medical- and pharmaceutical industry at any cost—including the lives of millions of people.
Sources: Burzynskimovie.com
Dr. Mercola's Comments:
Dr. Stanislaw Burzynski was born in the early 1940's in Poland, and was trained as both a biochemist and a physician. He's spent the last 35 years developing and successfully treating cancer patients suffering with some of the most lethal forms of cancer at his clinic in Houston, Texas.
I recently interviewed Dr. Burzynski about his cancer treatment—a gene-targeted approach using non-toxic peptides and amino acids, known as antineoplastons. Here, I will follow up with a review of his recently released documentary, Burzynski, The Movie.
It's an absolute jaw-dropper...
For anyone who has ever been affected by cancer, either directly or indirectly, the facts presented in this film will hit you like a rude slap in the face.
You will learn that not only did the US Federal government spend 14 years actively suppressing a cancer treatment that had a FAR greater success rate than any other treatment available, they also spent well over $60 million of US taxpayer dollars trying to put the inventor of the treatment in jail in order to steal his patents and either suppress or cash in on his discovery.
This film is an absolute MUST-SEE, as the summary I'm about to present below simply cannot do it justice. It's available for purchase at BurzynkiMovie.com, where you can view the first half-hour for free. The site also contains a large number of video clips, as well as a full transcript of the entire film, along with links to all the documentation presented.
What's so Special about Dr. Burzynski's Treatment?
The story begins back in the early 1970's when Dr. Burzynski discovered that people with cancer lacked a certain peptide, while those who were cancer free had a plentiful supply of it.
This finding eventually led him to create a medical treatment referred to as antineoplastons. The drug contains a mixture of peptides and derivatives of amino acids. These were known to act as molecular switches, but as genome research blossomed and science progressed, Dr. Burzynski discovered they also work as genetic switches, and that is why antineoplastons work so well. They're actually able to turn on cancer suppressing genes, while simultaneously turning oncogenes (cancer genes) off.
As explained in the film:
"Our bodies contain two categories of genes that allow cancer to flourish: oncogenes, and tumor suppressor genes. When someone has cancer, they have a higher level of oncogenes switched on, with a higher level tumor suppressor genes switched off.
The goal is to tell the body to both switch back on the tumor suppressor genes, and turn off as many oncogenes as possible."
While other gene targeting cancer drugs now exist, they're only capable of targeting a small number of specific cancer genes. Antineoplastons, on the other hand, targets a wide spectrum of cancer genes—about 100 of them at once. In a very simplistic way, antineoplastons are to cancer what a broad-spectrum antibiotic is to infectious disease.
Success Rates of Chemo and Radiation versus Antineoplastons
The film features several remarkable case stories of people who were successfully cured of cancer, but it's when the clinical trial data of conventional therapies versus antineoplastons are stacked against each other that the benefits of antineoplastons become really obvious:
Radiation or Chemotherapy Only Antineoplastons Only 5 of 54 patients (9 percent) were cancer free at the end of treatment 5 of 20 (25 percent) were cancer free at the end of treatment Toxic side effects No toxic side effects Tackling Childhood Brain Tumors
Dr. Burzynski was so confident in his antineoplastons that he even accepted the most difficult and "hopeless" cases, such as childhood brain tumors. Conventional medicine has little or nothing to offer in these cases, and the side effects can be as horrific as the disease itself, if not more. Furthermore, the best outcome conventional treatment can offer is to slow down the growth of the tumor.
Using antineoplastons, however, Dr. Burzynski has been able to successfully cure many of these otherwise hopeless cases, such as Jessica Ressel.
She was 11 years old when she was diagnosed with brainstem glioma—an incurable brain tumor. After learning that she would die no matter what toxic drugs and radiation treatments she underwent, the family decided to not put her through it. When they found Dr. Burzynski, they literally had nothing to lose...
Twelve months later—after having initially been told she had but a few months to live, and given no chance of survival at all—MRI's confirmed she was cancer-free. Her brain tumor was completely resolved. Today, Jessica is a healthy 24-year old woman, pregnant with her second child.
When comparing FDA-supervised studies of treatments for lethal childhood brainstem gliomas, antineoplastons again comes out as a clear winner:
Chemotherapy Only Antineoplastons Only 1 of 107 patients (0.9 percent) were cancer free at end of treatment 11 of 40 patients (27.5 percent) were cancer free at end of treatment 0 of 107 patients (0 percent) survived past five years 11 of 40 patients (27.5 percent) survived past five years Even more interesting, while some of Dr. Burzynski's patients did eventually die after the five-year mark, most who did NOT undergo chemotherapy prior to getting antineoplastons have gone on to live normal, healthy lives—yet another indication that in many cases, the conventional treatments are more lethal than the disease itself.
Side Effects of Chemotherapy Drugs
Here's just a sampling of the side effects of three conventional chemotherapy drugs:
Doxorubicin (nick-name: Red Death)—leukemia, heart failure, infertility, mouth sores Etoposide—leukemia, nerve damage, inability to fight infections Cisplatin—kidney damage, hearing damage, nerve damage, infertility Another chemo drug, Mitotane, which is derived from DDT, is also used for pediatric patients even though no studies have ever been performed to ascertain its safety or effectiveness in children.
Dr. Burzynski's Troubles Begins...
The legal battle Dr. Burzynski found himself embroiled in over his invention is convoluted to say the least. There are many bizarre twists and turns, and I strongly urge you to watch the documentary to fully appreciate what happened.
Dr. Burzynski had tried to get the FDA to review and approve antineoplastons since 1977, to no avail. To make sure he would not get into trouble for using the experimental therapy in his practice, his legal team reviewed federal and Texas state laws, confirming that he was acting within the laws and could use antineoplastons in his own practice "to meet the immediate needs of patients," since he was a licensed physician. Particularly if no other alternatives were available to the patient. He could not engage in interstate commerce, however, so he had to restrict the use of the drug to his home state of Texas.
But word spread, and patients started traveling to his office from out of state.
Suddenly, in 1984, he found out that agents from the Texas board of medical examiners were traveling to patients across the country trying to convince them to file charges against him.
What followed next truly challenges the rational mind.
Texas Board of Medical Examiners Try to Strip Away his Medical License
In 1988, despite not breaking any laws, and having produced more evidence than was required to show that his treatment was effective and that no harm was coming to his patients from it, the Texas medical board charged him with breaking a law that didn't exist, claiming it was grounds for revoking his medical license.
They didn't have a case, but kept the charges going by continuing to file slightly amended complaints, until finally, in 1993, the case went to trial. By then, 60 of Dr. Burzynski's patients had filed a petition for the medical board to stop harassing their doctor—a petition that the board successfully eliminated from the trial by filing a motion to strike it from the record.
Testifying on Dr. Burzynski's behalf, however, was a leading expert from none other than the National Cancer Institute (NCI), Dr. Nicholas Patronas, MD, a board certified radiologist since 1973, and the founder and chief of Neurology at the NCI. Even he recognized the absurdity of the board's case, and put his own career on the line to testify.
The judge ruled in Dr. Burzynski's favor, confirming that no laws had been broken.
You'd think that would be the end of it. But not so in this case. Instead of accepting defeat, the Texas medical board filed charges against Dr. Burzynski with the Texas Supreme Court.
The Method Behind the FDA's Madness
It eventually came to light that the US Food and Drug Administration (FDA) had pressured the Texas medical board to revoke Dr. Burzynski's medical license—despite the fact that no laws were broken, and his treatment was proven safe and effective.
But WHY?
It's been stated many times that a crime can be solved simply by following the money, and this case is no exception. The FDA and the pharmaceutical industry had realized that if Dr. Burzynski's discovery—which he owned the patent for—received a fair review, chemotherapy and radiation would rapidly dwindle into obscurity, effectively crippling the industry. Not only that, but if antineoplastons were approved, billions of dollars of cancer research funds would get funneled over to one single scientist who had exclusive patent rights...
Dr. Richard Crout, Director of the FDA Bureau of Drugs, once wrote in a 1982 newsletter:
"I never have and never will approve a new drug to an individual, but only to a large pharmaceutical firm with unlimited finances."
It became clear that ever since 1977, when Dr. Burzynski first tried to get antineoplastons approved, the FDA had begun scheming to eliminate the threat he and his discovery posed to the entire cancer industry...
The Harassment Continues Unabated
The FDA, under the direction of Commissioner Dr. David Kessler, called no fewer than FOUR different grand jury investigations into Dr. Burzynski's practice, despite the fact that none of the grand juries ever found him to be at fault, and no indictment ever came from any of the investigations.
But the FDA did not let up.
Finally, in 1995, just days after the final grand jury investigation, which also had found no fault, Dr. Burzynski was inexplicably indicted on charges of fraud, and 75 counts of violating federal law. If found guilty, he now faced 290 years in federal prison, and $18.5 million in fines.
A year later, in a bizarre twist brought about by congressional and public pressure, the FDA agreed to accept all of Dr. Burzynski's patients into a series of 72 FDA-supervised phase 2 clinical trials.
A 1996 article in The Washington Post noted:
"The prosecution marks the first time the FDA has tried to jail a scientist for using a drug on which he is conducting FDA authorized clinical trials."
Federal Government Spent $60 Million Trying to Bury Dr. Burzynski
This second trial cost American tax payers a whopping $60 million just in legal fees alone—that's not counting the cost of continually harassing him (including several raids on his office) and his patients over the preceding 11 years. Dr. Burzynski spent $2.2 million on his own defense, $700,000 of which was raised by Dr. Julian Whitaker through requests for donations in his newsletter Health & Healing.
On March 4, 1997, the judge declared it a mistrial, due to a deadlocked jury. However, after stating the government had not presented sufficient evidence in its case, he ordered that Dr. Burzynski be acquitted of 42 of the 75 counts.
But the FDA wasn't done yet. They took him to court AGAIN!
Third Time's the Charm...
At this point, many were becoming increasingly aware that something very bizarre and unusual was going on. Jurors from the first trial even joined patients in protests outside the court house. One clear-headed juror from the previous trial stated:
"Please don't waste my money abusing the system to make sure that you maintain your power!"
On May 28, 1997, after three hours of deliberation, the jury came back with their final verdict: Not Guilty.
By now you're probably thinking that this victory surely must mark the end of the wrongful harassment of Dr. Burzynski.
But no. It gets worse.
Secret Dealings Hide True Intents
While this ongoing drama unfolded over the course of more than a decade, something even more sinister was taking place behind the scenes, unbeknownst to Dr. Burzynski and his legal counsel.
In 1989, Dr. Burzynski had retained Dr. Dvorit Samid as a research consultant, and she did a lot of work with the antineoplaston ingredients. At the time, Dr. Samid worked at the Uniformed Services Medical School in Baltimore. She later transferred to the National Cancer Institute.
By 1990—while the Texas medical board kept filing one amended complaint after the other against Dr. Burzynski, in an effort to revoke his license—he had decided that the easiest way to keep the government from putting him out of business or in prison, was to partner with a pharmaceutical company. As luck would have it, he'd treated the sister-in-law of the Chairman and CEO of Élan Pharmaceuticals, and Élan eagerly drafted a letter of intent stating they would aggressively pursue the filing of the necessary protocols with the FDA for approval and marketing of antineoplastons.
Dr. Samid began working closely with Élan on the project. But once the financing, licensing agreements and royalties had been negotiated and agreed upon, Élan suddenly changed its tune, stating they had significant doubt as to whether the active substances could be patented, which would render an agreement meaningless.
As it turns out, Élan had instead partnered with the National Cancer Institute (NCI), where Dr. Samid got the position of section chief. They then co-sponsored laboratory research and clinical trials on just one of the antineoplastons' ingredients—an ingredient that Dr. Burzynski had NOT been able to patent due to the fact that it was already known. However, he had also already determined it to be very limited in terms of effectiveness on its own, over a decade ago.
Élan and the NCI spent tens of millions of dollars testing this single ingredient... Not surprisingly, it failed. Dr. Burzynski had already established that the ingredients must be used in combination in order to be effective. After realizing they could not duplicate the effectiveness of Dr. Burzynski's antineoplastons, the NCI finally agreed to conduct his clinical trials under the direction of Dr. Michael Friedman.
Sabotaging Trials—Par the Course for the National Cancer Institute
How do you sabotage a clinical trial?
It's actually easier than you might think. You'll have to watch the film to get all the details, but in summary, the trials were closed prior to completion, and were written off with the statement that "no conclusion can be made about the effectiveness or toxicity of antineoplastons." But it was clear, based on the study data, that seven of the nine patients enrolled received NO antineoplastons whatsoever! The others received dosages that were far lower than recommended.
Adding insult to injury, in 1999, about a year after Dr. Burzynski had been acquitted a third and final time, the NCI published these invalid trials in the medical literature, citing antineoplastons as a complete failure. So sure, Dr. Burzynski was a free man; cleared of all charges and free to practice medicine, but now the National Cancer Institute had effectively undermined the credibility and commercial viability of his medical discovery...
What the film reveals next, truly boggles the mind.
After the National Cancer Institute intentionally violated all protocols of their own antineoplaston trials, and after all state and federal agencies had failed in their 14-year campaign to remove Burzynski from society—after all of the dust settled—a profound truth began to emerge.
Theft and Patent Infringement—All in a Day's Work
In October 1991—while the Texas medical board kept filing amended complaints against him in an effort to revoke his license, due to pressure from the FDA—the National Cancer Institute (NCI) had conducted a site visit to Dr. Burzynski's clinic, and verified that "anti-tumor activity was documented by the use of antineoplastons."
As it turns out, a mere 17 days after this visit, the United States of America as represented by "The Department of Health and Human Services," filed a patent for antineoplastons AS2-1... one of the two antineoplastons Dr. Burzynski had already patented.
The inventor listed?
"Dr. Dvorit Samid," Dr. Burzynski's former research consultant. The patent states:
"The invention described herein may be manufactured, used and licensed by or for the government, for governmental purposes, without the payment to us of any royalties thereon."
Over the next four years, while the witch hunt to put Dr. Burzynski behind bars was in full swing, the US Government filed 10 more patents antineoplastons.
By the summer of 1995, around the time that Burzynski was indicted for fraud and 75 counts of violating federal law, Dr. Michael Friedman—who sabotaged the NCI antineoplastons trials—had left the NCI and become Deputy Commissioner of Operations for the FDA, working directly under FDA Commissioner Dr. David Kessler—the man responsible for dragging Dr. Burzynski in front of no less than four different grand juries a few years earlier.
In November of 1995, a month into Dr. Burzynski's trial, where he faced 290 years in prison, the US Patent office approved the first US Government patent for antineoplastons. Between 1995 and 2000, the US Patent office approved all 11 copycat patents on antineoplastons AS2-1....
Who Pays for Their Crimes?
By now your head is probably spinning, so let's recap.
Dr. Burzynski developed a cancer treatment that surpassed all other treatments on the market, and the FDA, the pharmaceutical industry, and the National Cancer Institute all knew it. They also knew he was the sole owner of the patents for this therapy, and these two facts combined, threatened the entire paradigm of the cancer industry.
The cancer paradigm is based on very expensive machines and toxic drugs. There's an enormous amount of money to be made in this paradigm, and Dr. Burzynski single-handedly threatened to overturn it.
So they tried to copy his invention using a single non-patented ingredient. It failed. The next step was to steal the whole thing right from under him. There was just one problem. They knew they couldn't use the stolen patents as long as Dr. Burzynski walked free and had the ability to defend his rights to them... So they concocted 75 fraudulent charges to tuck him away in jail for the rest of his life.
Fortunately for us, they failed in that too.
Dr. Whitaker sums it up nicely when he says:
"How can the US Patent office be corrupted to the point they issue patents for a medical treatment that's already been patented and issue them to someone who had nothing to do with their discovery or use? And how can the Patent office then assign these fraudulent patents to some of the most powerful institutions in the American government? And, imagine, all of this was done while these same agencies were spending millions of taxpayer dollars trying to put Dr. Burzynski in jail, so he could not fight the criminal theft of his discovery!"
As I said in the beginning, the facts of this case challenge the mind of any sane and rational person, but make no mistake about it: These things did happen, and Dr. Burzynski has all the documentation to back it up.
The US Government did harass and intimidate, and they did try to falsely imprison a brilliant scientist, simply because he'd discovered an effective cancer therapy, while simultaneously engaging in patent infringement.
Now, while this was an enormous personal hardship for Dr. Burzynski, the US Government also, through their enormous greed, in a very direct way prevented millions of cancer patients to receive a non-toxic therapy that could have saved their life. Remember, Dr. Burzynski has been trying to get antineoplastons reviewed and approved since 1977, to no avail. It's absolutely heartbreaking to consider the cost of this criminal behavior in terms of human life, including young children.
The Deadly, But Highly Profitable, Cancer Paradigm
While the stolen patents are filled with useful information about the benefits and efficacy of antineoplastons, one statement in particular sums up the problem with the current cancer paradigm:
"Current approaches to combat cancer rely primarily on the use of chemicals and radiation, which are themselves carcinogenic and may promote recurrences and the development of metastatic disease."
Dr. Burzynski's therapy, as you may recall, is non-toxic, giving patients the option to at least not suffer more grievous harm from the treatment itself, in addition to a significantly greater chance of being cured.
I'm sure that whenever someone donates their hard-earned money or participates in a pink-ribbon walkathon, they believe they're doing a good thing. They believe they're helping fund vital cancer research that will hopefully, some day, find a cure for cancer. Little do they know that much of this money goes toward perpetuating the status quo of cancer treatment, namely highly toxic drugs and expensive machines—the same old paradigm centered around profit.
As of 2010, the National Cancer Institute's annual budget is $5.2 billion. Dr. Burzynski cannot get a single dime of it. All of his research into antineoplastons over the past 35 years has been self-funded.
Think about that for a moment. Not one dime has been funneled toward developing one of the most promising cancer therapies to emerge in the past three decades... Are you still convinced they have your best interest at heart, and are diligently working to "find a cure for cancer"?
The best deals on Electronics for a limited time only!
When Father Kills Mother: Guiding Children Through Trauma and Grief
Footflexes is on Facebook - check us out here
FREE TAROT READINGS Lotus Tarot card readings can show you a fresh perspective on your life. Lotus Tarot
office makover teleseries **This is for entrepreneurs and solopreneurs that have a home office.**
Free 4 Part TeleSeries


text:
Reference Question of the Week – 7/15/12
July 21st, 2012This was kind of a fun question. Earlier this week, we received the following email message from a patron:
I have been referred to you by Town Hall. I am hoping to find some archived material relating to the tornado that hit Chelmsford on 21 July 1972. I am quite interested in learning more about the precise path the tornado took through town, the response by the town, and, since I am a meteorologist, more about the weather situation on that day.
This was actually the first time I'd ever heard of this tornado. I knew we wouldn't have any books or anything on such a local phenomena for this time period, so the first place I looked for information was the library's secret weapon, the Vertical File.
A few years ago, staff indexed our vertical file into an Excel spreadsheet, so doing a word search for "tornado" was a snap - and produced these two news clippings:
- Tornado hits town; Chelmsford Newsweekly, 7/27/1972; article; photographs
- Tornado strikes Chelmsford; Chelmsford Sentinel, 7/26/1972; article
We also have the entire newspaper from this time on microfilm, which might also contain additional information.
Of course, both of these resources require the patron to come into the library. The Town of Chelmsford's Annual Reports are available online (thanks to the Boston Public Library and the Internet Archive), and searching the 1972 annual report for "tornado" turned up a few matches concerning the Town's response and the overall cost.
I wasn't sure if NOAA would have any information on this storm, but a general web search found http://www.tornadohistoryproject.com, and their entry for this storm gives a very general storm track (zoom out one level).
I emailed all this to the patron, who was very appreciative. He had actually already found some NOAA/NWS information, and sent me the link to the storm summary [pdf, page 9] from the National Climatic Data Center's Storm Data and Unusual Phenomena data files:
This is now one of my favorite reference questions, because:
- I was able to provide the patron with helpful information
- I got to answer it using both new and traditional library resources
- Useful resources were located quickly using a finding aide developed by library staff
- I got to share a new library resource (online annual reports) with a patron, who may use it again in the future
- I learned something about the history of my community
- The patron participated in the search, even sharing his findings with me
- I learned of a new and useful weather resource from the patron
- I was able to add to our Vertical File the information the patron shared with me, thus improving our own resources
- The timing was so perfect that I get to post this question on the 40th anniversary of the tornado
All good stuff. The patron said he'd be into the library soon to take a look at the news clippings, and I'll be ready and waiting with the Vertical File when he comes.


text:
There are no reviews yet.
Micron Group Inc. Heavy Duty #10 Plastic Eyelets offer a 1 3/8″ hole size after setting and are made from durable plastic material. Micron Group Plastic Grommets comes with various color options. Our Grommets are suitable for various fabrics up to a thickness of 4mm by adjustable distance between the grommets halves.
• This durable plastic grommets can be used in Curtain / Drapery and home decoration.
Plastic Grommets are made of ABS Material; As its name implies, ABS is created from Acrylonitrile, Butadiene and Styrene polymers. This property of ABS makes it a desirable material for recycling. We recommend our Cutter and Cutting Board to achieve the perfect hole size to be cut out of your fabric or material. Also, by using our Rubber Mallet, you can attach the Eyelets securely and without causing any damage.
Please take a look to the chart in order to find the dimensions you need for every size and finishes of Plastic grommets manufactured by Micron America.
There are no reviews yet.


text:
Arbitrator's Award Reinstated in MOU Dispute
May 20, 2016
The Ninth Circuit has reinstated an arbitration decision that had been vacated by the U.S. District Court. In SW Reg. Council of Carpenters v. Drywall Dynamics, Inc. (9th Cir. 14-55250 5/19/16), the arbitrator ruled that an employer was bound by a memorandum of understanding extending the term of a labor agreement. The district court vacated the arbitration award on the grounds that the arbitrator's interpretation of the parties' agreement was not plausible and was contrary to public policy. The Ninth Circuit held that the district court's decision exceeded its narrow authority to determine whether the arbitrator's award was based on the parties' contract and whether it violated an explicit, well-defined, and dominant public policy. You can read the entire opinion at this link. [PDF]


text: In the Léon Brillouin Laboratory (LLB), and for the community of neutron scattering, this month of March 2021 was marked by an important event: the first neutron beam of the SHARP* instrument, a new time-of-flight neutron spectrometer, at the European reactor of the Institut Laue Langevin (ILL) in Grenoble. The result of a close CEA-CNRS-ILL collaboration, with the contribution of the Franco-Swedish agreement for neutron scattering instrumentation, this new device replaces the IN6 spectrometer, installed since the mid-1980s at the Institut Laue Langevin in Grenoble. The very first studies show that the device is fully operational and will soon be open to experimental projects. |


text:
Tis the season to be voting - well, at least in Georgia yet again. For the second time in as many years, voters there will decide who will represent them in the U.S. Senate in a December runoff. Incumbent Senator Raphael Warnock, a Democrat, faces Republican Herschel Walker. Georgia Public Broadcasting's Stephen Fowler joins me now to explain the state of the race.
Now, Stephen, it seems like we've seen this movie before - a closely divided battleground Senate contest heading into overtime in Georgia, lots of cash and attention focused on the candidates. Is this going to be a repeat of the runoff we saw after the 2020 presidential election?
STEPHEN FOWLER, BYLINE: Well, Eric, think of it more like a reboot than a rerun. Yes, it's another Senate race decided in a runoff after no candidate got above the 50% mark in the general, and, yes, Georgians have been bombarded with mailers and TV ads and doorknockers urging them to get out to vote. But there have been some important changes since January 2021. The main tweak that's relevant changes the length of a runoff. Before, it was a nine-week runoff period, with three weeks of mandatory early voting. Now it's just four weeks after the general election. That's a much narrower window for all parties involved.
Consider this - campaigns don't have as much time to get out the vote. Elections officials have less time to prepare for the vote, and voters have a drastically shorter timeline to show up and vote before the December 6 Election Day. And mandatory statewide early voting only runs this Monday through Friday, though some counties have been able to open up in the last few days to serve voters.
DEGGANS: Now, I'm wondering about voter enthusiasm. The Democrats have already clinched control of the Senate. Has there been any sign that voters feel less motivated after Thanksgiving?
FOWLER: Well, there certainly is a sense of election fatigue in Georgia after a seemingly never-ending series of high-stakes elections, but motivation hasn't flagged. Democrats already have control of the chamber, but that 51st seat would end power-sharing on committees, weaken the influence of two Democrats that sometimes held up Democratic priorities and be a firewall for the 2024 Senate races on the ballot. And Republicans see the seat as a necessary pick-up to keep those divided committees. That, plus their narrow majority in the U.S. House, means they could have more control over the direction of Congress the next two years. Now, Eric, Democrats are also making this less about the next two years and more about six years and who's best to represent Georgia that time instead of the national implications.
DEGGANS: Well, we're seeing reports of long lines in some counties yesterday, after a lawsuit allowed Saturday voting. I'm wondering, is this a sign of voter enthusiasm, or are we seeing problems with conducting this election?
FOWLER: Well, as a reminder, optional Saturday voting was a relative last-minute addition after the state says it wasn't allowed and Democrats sued. So some counties didn't offer it because of staffing, and some offered fewer sites than they will later this week. There were long lines and frustrations in some places, but that's more a sign of enthusiasm than issues. Think of it like a theme park opening at Disney World. A ride, or polling site in this case, can only handle so many people per hour. So if there's a lot of people that line up before things open up or all at the same time, it creates this long line that takes a while to get through.
All told, nearly 70,000 people showed up on Saturday, and several counties are open today, too. So that's more people that are voting now, as opposed to on Election Day. And I know I sound like a broken record here, but even with all of this voting now, it really is going to come down to who ultimately shows up by the time polls close December 6 to see who's victorious.
DEGGANS: Well, that's Georgia Public Broadcasting's Stephen Fowler. Stephen, thank you.
FOWLER: Thank you. Transcript provided by NPR, Copyright NPR.


text:
Modo Eco Rhine PINK 46 prescription glasses
Sold out
ECO is the only eyewear brand made from 95% recycled content (Recycled Collection) or 63% biobased material (Biobased Collection) - plus they plant a tree for every frame sold (currently 1.4 million trees in Cameroon) . They encourage customers to reuse the ECO packaging and donate their old glasses to people in need, which would provide vision for 314 million adults and children around the world. ECO's mission is changing the game in the industry.


text:
Cybersecurity has long been paramount for businesses that utilize digital solutions, but it's even more essential for today's distributed workforces. As cloud and mobile technologies continue to prove their value, it's important that you take proactive steps to manage and protect company mobile devices. Here's what you should do.
Ensure mobile OS is up to date
The updates to Apple and Android operating systems (OS) improve overall user experience, but their most important function is to fix security vulnerabilities. Reduce your business's exposure to threats by installing updates for all devices as soon as they become available. Don't delay updates, as doing so gives cybercriminals ample time to exploit vulnerabilities on devices that run on an outdated OS.
Install business applications only
Downloading apps seems harmless. However, lenient policies on what should and shouldn't be downloaded on company mobile devices could lead to staff installing non-business-related apps, many of which are notorious for malicious advertising codes and other threats. It's imperative that employees download and install only business applications necessary for their work on their company-issued mobile devices.
Be careful when connecting to public Wi-Fi networks
Emergencies may compel your staff to use password-free Wi-Fi networks in hotels, airports, cafes, and other public places. Connecting to an open network can expose your confidential information and sensitive company data to cybercriminals connected to the same network.
You can avoid this by providing a practical internet data plan, preferably one that includes roaming services, for remote workers. And if connecting to a public Wi-Fi network is really necessary, using a reputable virtual private network (VPN) can help protect your sensitive data. A VPN creates a direct, secure connection for data from your end to your intended point on the internet.
Enable phone tracking tools
Losing a company-issued mobile device is unfortunate. Devices can be misplaced or stolen, but enabling Find My iPhone for iOS devices, GPS Phone Tracker for Android, or any device-tracking app helps users locate lost phones. Some also have the option to delete data on stolen devices. Downloading and setting up such an app takes only a few minutes and it will give you peace of mind knowing that even if your phone is lost or stolen, its contents will not be compromised.
Screen SMS carefully
SMS phishing can be used to trick you into clicking malicious links. Cybercriminals send messages purporting to be from someone you know, asking you to urgently disclose confidential information. Should you encounter such an SMS, you can either delete it or alert your IT department. You can also block unknown senders without even opening their messages.
Mobile devices are becoming more critical to operations. And with more devices open to attacks, businesses must bolster their cybersecurity efforts. Malicious actors will exploit every possible vulnerability and that includes those in unsecured smartphones and tablets. Get in touch with us if you need comprehensive security solutions for your business.